PDWare MCP Server is available! Learn more →

Pharma portfolios,
planned on real capacity.

PDWare helps pharmaceutical companies optimize resource capacity, prioritize the right programs, and accelerate time-to-market — aligning clinical ops, R&D, regulatory, and manufacturing around what is feasible and most valuable.

For portfolio leaders, R&D operations, finance, and therapeutic-area leadership.

The constraint system

Why pharma runs on PDWare

Pharmaceutical organizations face unique constraints: limited specialist headcount, expensive lab equipment, strict regulatory timelines, and high program risk. PDWare models resource availability, runs scenario planning, and enforces portfolio governance — so pipeline decisions are data-driven and defensible.

DISCOVERYPRECLINICALCLINICALREGULATORY2 held — no biostatistics capacitySCARCE SPECIALIST CAPACITYClinical pharmacology96%Biostatistics104%Regulatory affairs88%IN PARALLELSustaining & lifecycle workdraws on the same specialists

Programs move through discovery, preclinical, clinical, and regulatory stages while scarce specialist capacity limits progression — sustaining work draws on the same people. Illustrative data.

Model the constraint

Tighten the specialist pool — watch the pipeline respond

Regulatory and CMC specialists gate every stage. Change how many exist, and choose what they protect: the filings, or the early pipeline.

Test the pipeline
8 FTE
514

With 8 of 12 needed specialists, 4 programs stall — first at the Discovery gate (ONC-214 waits). Filings stay protected; the early pipeline starves.

Pipeline vs specialist capacity8 FTE across 4 gates
Discovery0/11 program stalledONC-214 · waiting
Preclinical0/22 programs stalledIMM-402 · waitingCNS-118 · waiting
Clinical3/41 program stalledONC-187RARE-77CVD-355IMM-390 · waiting
Regulatory5/5fully staffedONC-101END-233CNS-090RARE-52CVD-301
Programs moving8 / 12 
Stalled4 
Specialist pool8 FTE 
StrategyProtect filings 
Illustrative portfolio data

One specialist keeps one program moving through its gate — a deliberate simplification of the real skill model, on an illustrative pipeline.

What changes with PDWare

What changes with PDWare

  1. Faster clinical program and pipeline prioritization decisions
  2. Real-time resource capacity forecasting for clinical trial staffing
  3. R&D budget and cost tracking aligned with staffing plans and submission schedules
  4. Audit-ready resource planning across process, people, and tools

What teams do with PDWare

What teams do with PDWare

Clinical operations & trial staffing

Model specialist demand across studies and sites; see shortfalls before they delay a trial.

Pipeline scenario planning

Compare portfolio scenarios by priority, budget, and capacity — decide which programs advance with evidence.

Regulatory milestone alignment

Keep staffing plans synchronized with submission schedules and regulatory gates.

In good company

Customers in this industry

Eli Lilly logoPfizer logoPerkinElmer logoNatera logoPacBio logoHospira logo

Logos as published on pdware.com. All trademarks belong to their owners.

Common questions

Common questions
How does PDWare handle the scarcity of specialist skills in pharma R&D?
PDWare models demand and capacity at the skill level — not just headcount — so leadership sees where scientists, statisticians, or regulatory specialists are over-committed, and which programs are affected.
Can PDWare support portfolio governance for regulated R&D?
Yes. Prioritization, scenario comparison, and approval workflows produce a defensible, auditable record of why programs were funded, deferred, or stopped.

Model your industry constraints.

A tailored session on the constraint system above — with your programs, skills, and timelines.

Also serving: Medical devices · Manufacturing & hi-tech · IT · Finance · Healthcare · Consulting